Our measurements show a significant difference in the levels of β2M between 5 patients referred with a suspicion of PCa, but prostate biopsies showed no evidence for cancer (controls) and 10 PCa patients (5 with local PCa and 5 with metastatic PCa). The gene discussed is B2M; the disease is posterior cortical atrophy.